Teligent announced that the Food and Drug Administration (FDA) has approved Triamcinolone Acetonide Ointment, 0.1%. Triamcinolone Acetonide Ointment is a topical steroid indicated for the relief of ...
Triamcinolone acetonide 0.1%, nystatin 100000units/g; crm; oint. Avoid prolonged use or on large areas. Use lowest effective dose (esp. in children). Do not occlude. Discontinue gradually in chronic ...
BUENA, N.J., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s ...
New Delhi: Glenmark Pharmaceuticals Ltd on Wednesday said it has received final approval from the US health regulator for generic Triamcinolone Acetonide ointment used for treating skin inflammation.
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated August 08, 2016 titled "Glenmark Pharmaceuticals receives ANDA approval for Triamcinolone Acetonide Cream USP, 0.1%".
CHICAGO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- MidAmerica Pharmaceuticals today announced that it is bringing KOURZEQ™ (triamcinolone acetonide dental paste USP, 0.1%) - a new option for the treatment of ...
* Teligent, Inc announces FDA approval of triamcinolone acetonide ointment usp, 0.1% Source text for Eikon: Further company coverage: Sign up here. The Russian central bank will keep its benchmark ...
Share price of Strides Pharma Science slipped 3 percent intraday Wednesday. The company's step-down wholly owned subsidiary, Strides Pharma Global Pte, Singapore, has received approval for ...
* Teligent inc - expect to launch triamcinolone acetonide cream USP, 0.1% in Q4 of 2017 Source text for Eikon: Further company coverage: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback